Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Mazzone

Showing results (41-50 of 54) with videos related to

Pageof 6
Sort By:
Neuromuscular Disorders : NMD|February 4, 2026
Refining functional phenotypes in an international cohort of untreated paediatric type 2 and 3 SMA patients using the Revised Hammersmith ScaleE Milev, G Stimpson, D Ramsey, et al.
Neuromuscular Disorders : NMD|January 7, 2018
Diagnosis and management of spinal muscular atrophy: Part 2: Pulmonary and acute care; medications, supplements and immunizations; other organ systems; and ethicsRichard S Finkel, Eugenio Mercuri, Oscar H Meyer, et al.
The New England Journal of Medicine|February 15, 2018
Nusinersen versus Sham Control in Later-Onset Spinal Muscular AtrophyEugenio Mercuri, Basil T Darras, Claudia A Chiriboga, et al.
Muscle & Nerve|January 25, 2019
Revised upper limb module for spinal muscular atrophy: 12 month changesMaria Carmela Pera, Giorgia Coratti, Elena S Mazzone, et al.
Plos One|February 22, 2017
Revised Hammersmith Scale for spinal muscular atrophy: A SMA specific clinical outcome assessment toolDanielle Ramsey, Mariacristina Scoto, Anna Mayhew, et al.
Muscle & Nerve|October 5, 2016
Revised upper limb module for spinal muscular atrophy: Development of a new moduleElena S Mazzone, Anna Mayhew, Jacqueline Montes, et al.
Plos One|June 27, 2018
Ambulatory function in spinal muscular atrophy: Age-related patterns of progressionJacqueline Montes, Michael P McDermott, Elizabeth Mirek, et al.
BMC Neurology|February 25, 2017
Content validity and clinical meaningfulness of the HFMSE in spinal muscular atrophyMaria C Pera, Giorgia Coratti, Nicola Forcina, et al.
Neuromuscular Disorders : NMD|January 19, 2016
Patterns of disease progression in type 2 and 3 SMA: Implications for clinical trialsEugenio Mercuri, Richard Finkel, Jacqueline Montes, et al.
Pediatric Physical Therapy : the Official Publication of the Section on Pediatrics of the American Physical Therapy Association|June 21, 2018
Quantitative Evaluation of Lower Extremity Joint Contractures in Spinal Muscular Atrophy: Implications for Motor FunctionRachel Salazar, Jacqueline Montes, Sally Dunaway Young, et al.
Pageof 6

Showing results (41-50 of 54) with videos related to

Sort By:
Pageof 6
Neuromuscular Disorders : NMD|February 4, 2026
Refining functional phenotypes in an international cohort of untreated paediatric type 2 and 3 SMA patients using the Revised Hammersmith ScaleE Milev, G Stimpson, D Ramsey, et al.
Neuromuscular Disorders : NMD|January 7, 2018
Diagnosis and management of spinal muscular atrophy: Part 2: Pulmonary and acute care; medications, supplements and immunizations; other organ systems; and ethicsRichard S Finkel, Eugenio Mercuri, Oscar H Meyer, et al.
The New England Journal of Medicine|February 15, 2018
Nusinersen versus Sham Control in Later-Onset Spinal Muscular AtrophyEugenio Mercuri, Basil T Darras, Claudia A Chiriboga, et al.
Muscle & Nerve|January 25, 2019
Revised upper limb module for spinal muscular atrophy: 12 month changesMaria Carmela Pera, Giorgia Coratti, Elena S Mazzone, et al.
Plos One|February 22, 2017
Revised Hammersmith Scale for spinal muscular atrophy: A SMA specific clinical outcome assessment toolDanielle Ramsey, Mariacristina Scoto, Anna Mayhew, et al.
Muscle & Nerve|October 5, 2016
Revised upper limb module for spinal muscular atrophy: Development of a new moduleElena S Mazzone, Anna Mayhew, Jacqueline Montes, et al.
Plos One|June 27, 2018
Ambulatory function in spinal muscular atrophy: Age-related patterns of progressionJacqueline Montes, Michael P McDermott, Elizabeth Mirek, et al.
BMC Neurology|February 25, 2017
Content validity and clinical meaningfulness of the HFMSE in spinal muscular atrophyMaria C Pera, Giorgia Coratti, Nicola Forcina, et al.
Neuromuscular Disorders : NMD|January 19, 2016
Patterns of disease progression in type 2 and 3 SMA: Implications for clinical trialsEugenio Mercuri, Richard Finkel, Jacqueline Montes, et al.
Pediatric Physical Therapy : the Official Publication of the Section on Pediatrics of the American Physical Therapy Association|June 21, 2018
Quantitative Evaluation of Lower Extremity Joint Contractures in Spinal Muscular Atrophy: Implications for Motor FunctionRachel Salazar, Jacqueline Montes, Sally Dunaway Young, et al.
Pageof 6